Rumor News
Most Popular Rumor Story
Rumor Mill: Novartis may bid for Bayer
Bayer stock is humming today on rumors that Novartis will mount a buyout of the giant German pharma company. European wire services quoted an offering price of €70 per share (about $94), citing... Read more...
Latest Headlines
- August 6, 2009
- September 9, 2008
- July 17, 2008
- May 14, 2008
- March 18, 2008
- August 16, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
